OpenFilings

InMed Pharmaceuticals Inc.

Form10-K/A

Report Period2022-06-30

Date Filed2022-09-28

Time Filed13:34:29

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

AMENDMENT NO. 1 TO FORM 10-K
DESCRIPTION OF SECURITIES OF INMED PHARMACEUTICALS INC
CONSULTING AGREEMENT DATED AS OF APRIL 1, 2022, BETWEEN INMED PHARMACEUTICALS IN
CERTIFICATION
CERTIFICATION
Filing on SEC Edgar